DRI seizes 'fighter' drug 'popular' among IS terrorists from

Bs_logoImage
Press Trust of India Ahmedabad
Last Updated : May 31 2018 | 10:20 PM IST

The Directorate of Revenue Intelligence (DRI) today seized a huge cache of Tramadol drug from a factory in Gujarat's Valsad district which officials said is popular among IS terrorists in the Middle East as a "fighter drug", and arrested two partners of the firm.

The agency said Tramadol is also popular in some African countries like Nigeria and Ghana.

The raid was conducted at a pharmaceutical firm located in Sarigam village after the DRI's Ahmedabad zonal unit received inputs about the illegal manufacture of the drug, which is banned under the Narcotic Drugs and Psychotropic Substances (NDPS) Act.

During the raid, DRI officials found out that the factory was being used for massive production of banned psychotropic drugs, the DRI said in a statement.

Two partners of the said firm were also arrested, it said.

The DRI seized 6.7 crore Tramadol tablets as well as capsules which were ready for dispatch. In addition, over two tonnes of loose Tramadol tablets and 870 kgs of raw material was also seized, it said.

Tramadol is a synthetic opioid drug which is in demand in Nigeria and Ghana where a large section of population is addicted to this drug as its consumption generates euphoria, DRI said.

"Tramadol drug is reportedly also very popular among ISIS terrorists in the war-zones of the Middle East. ISIS fighters use this drug to overcome pain and fatigue. That is why it is sometimes called as Fighter Drug," the agency stated.

Tramadol was brought under the NDPS Act in April 2018 given its wide misuse, the DRI said, adding that further investigation is on.

Disclaimer: No Business Standard Journalist was involved in creation of this content

Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 31 2018 | 10:20 PM IST